Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Artivion Dividend Announcement
• Artivion announced a quarterly dividend of $0.03 per ordinary share which will be made payable on 2015-12-18. Ex dividend date: 2015-12-09
• Artivion's trailing twelve-month (TTM) dividend yield is -%
Artivion Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2015-12-09 | $0.03 | quarterly | 2015-12-18 |
2015-09-09 | $0.03 | quarterly | 2015-09-18 |
2015-06-10 | $0.03 | quarterly | 2015-06-19 |
2015-03-11 | $0.03 | quarterly | 2015-03-20 |
2014-12-10 | $0.03 | quarterly | 2014-12-19 |
2014-09-10 | $0.03 | quarterly | 2014-09-19 |
2014-06-11 | $0.03 | quarterly | 2014-06-20 |
2014-03-12 | $0.03 | quarterly | 2014-03-21 |
2013-12-11 | $0.03 | quarterly | 2013-12-20 |
2013-09-11 | $0.03 | quarterly | 2013-09-20 |
2013-06-12 | $0.03 | quarterly | 2013-06-21 |
2013-03-12 | $0.03 | quarterly | 2013-03-21 |
2012-12-12 | $0.03 | quarterly | 2012-12-21 |
2012-09-12 | $0.03 | quarterly | 2012-09-21 |
Artivion Dividend per year
Artivion Dividend growth
Artivion Dividend Yield
Artivion current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Artivion stock? Use our calculator to estimate your expected dividend yield:
Artivion Financial Ratios
Artivion Dividend FAQ
Other factors to consider when evaluating Artivion as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Artivion stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Artivion's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Artivion publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Artivion distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Artivion are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Artivion sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Artivion distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Artivion declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Artivion's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Artivion's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.